These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

738 related articles for article (PubMed ID: 33162353)

  • 1. In-vitro assessment of first-line antifungal drugs against Aspergillus spp. caused human keratomycoses.
    Hassan AS; Sangeetha AB; Shobana CS; Mythili A; Suresh S; Abirami B; Alharbi RA; Aloyuni SA; Abdel-Hadi A; Awad MF; Ismail RM; Panneer Selvam K; Manikandan P
    J Infect Public Health; 2020 Dec; 13(12):1907-1911. PubMed ID: 33162353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro susceptibility of filamentous fungi from mycotic keratitis to azole drugs.
    Shobana CS; Mythili A; Homa M; Galgóczy L; Priya R; Babu Singh YR; Panneerselvam K; Vágvölgyi C; Kredics L; Narendran V; Manikandan P
    J Mycol Med; 2015 Mar; 25(1):44-9. PubMed ID: 25541256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fungal Keratitis: Epidemiology, Rapid Detection, and Antifungal Susceptibilities of
    Manikandan P; Abdel-Hadi A; Randhir Babu Singh Y; Revathi R; Anita R; Banawas S; Bin Dukhyil AA; Alshehri B; Shobana CS; Panneer Selvam K; Narendran V
    Biomed Res Int; 2019; 2019():6395840. PubMed ID: 30800674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of Aspergillus keratitis at a tertiary care eye hospital in South India and antifungal susceptibilities of the causative agents.
    Manikandan P; Varga J; Kocsubé S; Anita R; Revathi R; Németh TM; Narendran V; Vágvölgyi C; Panneer Selvam K; Shobana CS; Babu Singh YR; Kredics L
    Mycoses; 2013 Jan; 56(1):26-33. PubMed ID: 22487304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Necessity to identify the causative agent for appropriate treatment in fungal corneal ulcer: an in vitro study.
    Gupta MK; Chandra A; Prakash P; Tilak R
    J Mycol Med; 2018 Mar; 28(1):201-205. PubMed ID: 29398639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of Antifungal Resistance in Adult Patients With Fungal Keratitis in South India: A Post Hoc Analysis of 3 Randomized Clinical Trials.
    Prajna NV; Lalitha P; Krishnan T; Rajaraman R; Radnakrishnan N; Srinivasan M; Devi L; Das M; Liu Z; Zegans ME; Acharya NR; Porco TC; Lietman TM; Rose-Nussbaumer J
    JAMA Ophthalmol; 2022 Feb; 140(2):179-184. PubMed ID: 35024776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro susceptibility patterns of Aspergillus and Fusarium species isolated from equine ulcerative keratomycosis cases in the midwestern and southern United States with inclusion of the new antifungal agent voriconazole.
    Pearce JW; Giuliano EA; Moore CP
    Vet Ophthalmol; 2009; 12(5):318-24. PubMed ID: 19751493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of
    Homa M; Manikandan P; Szekeres A; Kiss N; Kocsubé S; Kredics L; Alshehri B; Dukhyil AAB; Revathi R; Narendran V; Vágvölgyi C; Shobana CS; Papp T
    Front Microbiol; 2019; 10():2249. PubMed ID: 31649626
    [No Abstract]   [Full Text] [Related]  

  • 9. Antimicrobial susceptibility of Fusarium, Aspergillus, and other filamentous fungi isolated from keratitis.
    Lalitha P; Shapiro BL; Srinivasan M; Prajna NV; Acharya NR; Fothergill AW; Ruiz J; Chidambaram JD; Maxey KJ; Hong KC; McLeod SD; Lietman TM
    Arch Ophthalmol; 2007 Jun; 125(6):789-93. PubMed ID: 17562990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study of the in vitro susceptibilities of clinical and laboratory-selected resistant isolates of Aspergillus spp. to amphotericin B, itraconazole, voriconazole and posaconazole (SCH 56592).
    Manavathu EK; Cutright JL; Loebenberg D; Chandrasekar PH
    J Antimicrob Chemother; 2000 Aug; 46(2):229-34. PubMed ID: 10933645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of Pathogens of Fungal Keratitis and the Sensitivity of Pathogenic Fungi to Therapeutic Agents with the Disk Diffusion Method.
    Wang L; Wang L; Han L; Yin W
    Curr Eye Res; 2015; 40(11):1095-101. PubMed ID: 26268399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro antifungal activity of silver nanoparticles against ocular pathogenic filamentous fungi.
    Xu Y; Gao C; Li X; He Y; Zhou L; Pang G; Sun S
    J Ocul Pharmacol Ther; 2013 Mar; 29(2):270-4. PubMed ID: 23410063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time-Kill Kinetics and In Vitro Antifungal Susceptibility of Non-fumigatus Aspergillus Species Isolated from Patients with Ocular Mycoses.
    Öz Y; Özdemir HG; Gökbolat E; Kiraz N; Ilkit M; Seyedmousavi S
    Mycopathologia; 2016 Apr; 181(3-4):225-33. PubMed ID: 26612621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility of fungi isolated from the respiratory tract of falcons to amphotericin B, itraconazole and voriconazole.
    Silvanose CD; Bailey TA; Di Somma A
    Vet Rec; 2006 Aug; 159(9):282-4. PubMed ID: 16946311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative efficacy of amphotericin B, clotrimazole and itraconazole against Aspergillus spp. An in vitro study.
    Hahn YH; Ahearn DG; Wilson LA
    Mycopathologia; 1993 Sep; 123(3):135-40. PubMed ID: 8302362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro susceptibility testing of Candida and Aspergillus spp. to voriconazole and other antifungal agents using Etest: results of a French multicentre study.
    Mallié M; Bastide JM; Blancard A; Bonnin A; Bretagne S; Cambon M; Chandenier J; Chauveau V; Couprie B; Datry A; Feuilhade M; Grillot R; Guiguen C; Lavarde V; Letscher V; Linas MD; Michel A; Morin O; Paugam A; Piens MA; Raberin H; Tissot E; Toubas D; Wade A
    Int J Antimicrob Agents; 2005 Apr; 25(4):321-8. PubMed ID: 15784312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In vitro activity of amphotericin B, itraconazole and voriconazole against 20 species of Aspergillus using the Sensititre microdilution method].
    García-Martos P; García-Agudo L; Gutiérrez-Calzada J; Ruiz-Aragón J; Saldarreaga A; Marín P
    Enferm Infecc Microbiol Clin; 2005 Jan; 23(1):15-8. PubMed ID: 15701327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infectious keratitis caused by Aspergillus tubingensis.
    Kredics L; Varga J; Kocsubé S; Rajaraman R; Raghavan A; Dóczi I; Bhaskar M; Németh TM; Antal Z; Venkatapathy N; Vágvölgyi C; Samson RA; Chockaiya M; Palanisamy M
    Cornea; 2009 Sep; 28(8):951-4. PubMed ID: 19654512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of Aspergillus species causing keratitis in Mexico.
    Al-Hatmi AMS; Castro MA; de Hoog GS; Badali H; Alvarado VF; Verweij PE; Meis JF; Zago VV
    Mycoses; 2019 Feb; 62(2):144-151. PubMed ID: 30256460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro synergy of natamycin and voriconazole against clinical isolates of
    Sradhanjali S; Yein B; Sharma S; Das S
    Br J Ophthalmol; 2018 Jan; 102(1):142-145. PubMed ID: 28982951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.